Published in Women's Health Weekly, February 10th, 2011
"Elicited antibodies were assessed for their ability to recognize the VEGF protein, inhibit angiogenesis, inhibit the interaction of VEGF with its receptor, and inhibit cancer growth in mice. Following immunization, high-titered elicited antibodies were shown to be specific for the full-length VEGF protein by ELISA and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly